PNT - POINT Biopharma Global Inc.
IEX Last Trade
12.51
12.510 100.000%
Share volume: 0
Last Updated: Tue 26 Dec 2023 09:07:44 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-13 | 2022-08-12 | 2022-11-14 | 2023-03-27 | 2023-05-15 | 2023-08-14 | |
| Assets | |||||||
| Total Assets | 252.982 M | 234.245 M | 325.688 M | 578.323 M | 558.524 M | 497.775 M | |
| Current Assets | 232.614 M | 204.905 M | 296.231 M | 530.823 M | 434.580 M | 432.375 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 5.228 M | 5.472 M | 4.712 M | 5.611 M | 4.547 M | 5.750 M | |
| Short Term Investments | 5.228 M | 5.472 M | 4.712 M | 5.611 M | 4.547 M | 5.750 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 3.399 M | |
| Current Cash | 227.385 M | 199.433 M | 291.519 M | 525.212 M | 430.033 M | 423.226 M | |
| Total Non-current Assets | 20.368 M | 29.340 M | 29.457 M | 47.500 M | 123.944 M | 65.399 M | |
| Property Plant Equipment | 20.368 M | 24.441 M | 29.457 M | 31.381 M | 34.774 M | 48.394 M | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 5.029 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 252.982 M | 234.245 M | 325.688 M | 578.323 M | 558.524 M | 497.775 M | |
| Total liabilities | 13.708 M | 18.862 M | 16.608 M | 91.369 M | 86.744 M | 50.323 M | |
| Total current liabilities | 13.643 M | 18.797 M | 16.608 M | 79.738 M | 77.848 M | 41.156 M | |
| Accounts Payable | 6.120 M | 8.067 M | 3.199 M | 7.703 M | 15.919 M | 13.900 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 11.631 M | 8.897 M | 4.650 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.257 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 4.517 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 11.631 M | 8.897 M | 4.650 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 239.274 M | 215.382 M | 309.080 M | 486.954 M | 471.780 M | 447.452 M | |
| Common stock | 90.122 M | 90.124 M | 92.401 M | 105.757 M | 105.661 M | 105.724 M | |
| Retained earnings | -75.665 M | -100.246 M | -124.259 M | 39.009 M | 22.478 M | -2.933 M |